A New Jersey jury has assessed $2.62 million in damages against Hoffmann-La Roche Inc. and its Swiss parent company in the first of 400 suits to be tried over the acne drug Accutane's propensity to cause inflammatory bowel disease. However, the jury did not award punitive damages under the state's Consumer Fraud Act, because it found insufficient evidence that the manufacturer intentionally failed to warn that the drug can cause IBD.
June 07, 2007 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
In the first of 400 suits to be tried over the acne drug Accutane’s propensity to cause inflammatory bowel disease, an Atlantic County, N.J., jury has assessed $2.62 million in damages against Hoffmann-La Roche Inc. and its Swiss parent company.
However, the jury of six women and four men did not award punitive damages under New Jersey’s Consumer Fraud Act because they found insufficient evidence the manufacturer intentionally failed to warn the drug can cause IBD.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
